Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 55 entries
View as:

Denosumab vs Zoledronate After Vertebroplasty

Phase: N/A Priority: Normal
NCT ID: NCT05598606 Org: User:
Start: 01/12/21 End: 01/14/23 Due: 01/14/24

Denosumab and Screw Fixation for Osteoporotic Compression Fracture

Phase: N/A Priority: Normal
NCT ID: NCT05065164 Org: User:
Start: 09/14/21 End: 09/25/23 Due: 09/25/24

s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT05033535 Org: User:
Start: 07/01/20 End: 06/30/22 Due: 06/30/23

Denosumab and Osteoporotic Vertebral Compression Fracture

Phase: N/A Priority: Normal
NCT ID: NCT05058443 Org: User:
Start: 01/06/20 End: 08/10/22 Due: 08/10/23

Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study

Phase: N/A Priority: Normal
NCT ID: NCT04730648 Org: User:
Start: 04/22/21 End: 04/23/23 Due: 04/23/24

Combined Spinal-epidural Anesthesia for Cesarean Section Without Prophylactical Prehydration and Vasopressors

Phase: N/A Priority: Normal
NCT ID: NCT03497364 Org: User:
Start: 05/01/18 End: 11/30/21 Due: 11/30/22

Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03658577 Org: User:
Start: 03/02/18 End: 12/31/23 Due: 12/31/24

Denosumab vs Alendronate After Vertebroplasty

Phase: N/A Priority: Normal
NCT ID: NCT05662358 Org: User:
Start: 01/03/21 End: 10/25/23 Due: 10/25/24

Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients

Phase: N/A Priority: Normal
NCT ID: NCT04861389 Org: User:
Start: 01/01/21 End: 01/31/22 Due: 01/31/23

Bioabsorbable Scaffold vs Drug-coated Balloon for Coronary de Novo Lesions in STEMI: Prospective Observational Trial

Phase: N/A Priority: Normal
NCT ID: NCT04565561 Org: User:
Start: 10/01/20 End: 12/01/22 Due: 12/01/23

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Phase: N/A Priority: Normal
NCT ID: NCT03271255 Org: User:
Start: 05/23/18 End: 12/31/22 Due: 12/31/23

Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)

Phase: N/A Priority: Normal
NCT ID: NCT03743428 Org: User:
Start: 10/22/20 End: 12/31/26 Due: 12/31/27

Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03590262 Org: User:
Start: 01/01/18 End: 09/30/19 Due: 09/30/20

Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05441566 Org: User:
Start: 06/01/22 End: 12/31/26 Due: 12/31/27

Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03871205 Org: User:
Start: 04/01/19 End: 12/30/20 Due: 12/30/21

Denosumab vs Zoledronate After Lumbar Fusion

Phase: N/A Priority: Normal
NCT ID: NCT05638399 Org: User:
Start: 01/15/20 End: 02/28/23 Due: 02/28/24

Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum

Phase: N/A Priority: Normal
NCT ID: NCT05481866 Org: User:
Start: 10/31/22 End: 10/31/23 Due: 10/31/24

A COPD Quality Improvement Program（QIP）

Phase: N/A Priority: Normal
NCT ID: NCT05638646 Org: User:
Start: 11/25/22 End: 12/31/24 Due: 12/31/25

Multi-omics Study of Young Adults Coronary Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT04864457 Org: User:
Start: 07/01/20 End: 07/31/21 Due: 07/31/22

Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04948008 Org: User:
Start: 11/05/19 End: 12/31/22 Due: 12/31/23

Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03556631 Org: User:
Start: 09/01/20 End: 10/30/21 Due: 10/30/22

Medium Dose of Cytarabine and Mitoxantrone

Phase: N/A Priority: Normal
NCT ID: NCT04024241 Org: User:
Start: 09/01/17 End: 08/31/19 Due: 08/31/20

Clinical Study of NK Cells in the Treatment of Severe Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT03948828 Org: User:
Start: 06/01/19 End: 12/31/22 Due: 12/31/23

Comparisons of SWI, WWI and CI in Potentially Difficult Colonoscopy.

Phase: N/A Priority: Normal
NCT ID: NCT03571061 Org: User:
Start: 04/03/18 End: 12/26/18 Due: 12/26/19

S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT05553886 Org: User:
Start: 12/21/21 End: 12/31/26 Due: 12/31/27